Evaluation of Efficacy and Safety of FOLFIRI Association Treatment in Patients 70 Years of Age and Older With Gastric Cancer (CEPAFIRI)

This study has been completed.
Sponsor:
Collaborators:
Novartis
Sanofi-Synthelabo
Aventis Pharmaceuticals
Information provided by:
Institut Bergonié
ClinicalTrials.gov Identifier:
NCT00210184
First received: September 13, 2005
Last updated: December 29, 2011
Last verified: October 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: July 2009
  Estimated Primary Completion Date: No date given